Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells.
Chronic low-grade inflammation has emerged as a key contributor to the cardiovascular complications of diabetes, however, the mechanisms by which diabetes increases inflammation remain poorly understood. Here, we report that exposure to high glucose (HG) stimulates ectodomain shedding of TNF-alpha from rat aortic smooth muscle cells in culture. Our results show that exposure to HG decreases membrane-associated TNF-alpha. This decrease in unprocessed TNF-alpha was prevented by the aldose reductase (AR) inhibitor sorbinil and AR small interference RNA. Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA. HG-induced TACE phosphorylation and TNF-alpha processing were also prevented by TNF-alpha protease inhibitor-1, an inhibitor of TACE. Inhibition of protein kinase C (PKC)-delta by rottlerin prevented HG-induced TACE activation and the accumulation of unprocessed TNF-alpha. Treatment with sorbinil decreased elevated levels of circulating TNF-alpha in streptozotocin-treated diabetic rats. Sorbinil treatment also decreased the expression of TNF-alpha, matrix metalloproteinase-2, matrix metalloproteinase-9, and increased tissue inhibitor of metalloproteinase-3 in vascular smooth muscle cells treated with HG and in balloon-injured carotid arteries of diabetic rats. These results indicate that HG-induced TNF-alpha shedding could be attributed to TACE activation, which is regulated, in part, by PKC-delta and AR. Therefore, inhibition of TACE by TNF-alpha protease inhibitor-1, or pharmacological inhibition of PKC-delta or AR may represent useful strategies for treating vascular inflammation associated with diabetes.
Reddy
Aramati B M
AB
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555-0647, USA.
Ramana
Kota V
KV
Srivastava
Sanjay
S
Bhatnagar
Aruni
A
Srivastava
Satish K
SK
D051722:ADAM Proteins / Q000378:metabolism*; D000072198:ADAM17 Protein; D000449:Aldehyde Reductase / Q000378:metabolism*; D000818:Animals; D004151:Dipeptides / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology*; D006877:Hydroxamic Acids / Q000494:pharmacology; D007249:Inflammation / Q000517:prevention & control; D007700:Kinetics; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D019278:Matrix Metalloproteinase 3 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000201:enzymology*; D010766:Phosphorylation; D051745:Protein Kinase C-delta / Q000378:metabolism*; D051381:Rats; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D004151:Dipeptides; D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; C092152:N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide; D014409:Tumor Necrosis Factor-alpha; D000449:Aldehyde Reductase; D051745:Protein Kinase C-delta; D051722:ADAM Proteins; D019278:Matrix Metalloproteinase 3; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D000072198:ADAM17 Protein; C000606464:Adam17 protein, rat; D005947:Glucose
Diabetes Res Clin Pract. 2008 Jul;81(1):25-32
18485515
Diabetes. 2007 Jul;56(7):1834-41
17473225
J Cell Sci. 2005 Jun 1;118(Pt 11):2371-80
15923650
Nat Clin Pract Nephrol. 2005 Nov;1(1):33-43
16932362
Diabetes. 2002 Oct;51(10):3095-101
12351453
FEBS Lett. 1998 Sep 11;435(1):39-44
9755855
Endocr Rev. 2005 May;26(3):380-92
15814847
Diabetes. 2004 Nov;53(11):2910-20
15504972
Am J Cardiol. 1991 Jul 1;68(1):85-9
2058564
J Immunol. 1998 May 1;160(9):4570-9
9574564
Mol Aspects Med. 2008 Oct;29(5):258-89
18762209
Endocr Rev. 2006 May;27(3):242-59
16492903
Chem Rev. 2002 Dec;102(12):4627-38
12475204
Diabetes. 2006 Apr;55(4):1133-40
16567539
Nature. 1997 Feb 20;385(6618):729-33
9034190
J Immunol. 2000 Apr 15;164(8):4277-85
10754326
Trends Immunol. 2004 Jan;25(1):4-7
14698276
Circulation. 2002 Oct 15;106(16):2067-72
12379575
Diabetes. 2002 Apr;51(4):1157-65
11916939
Nature. 1997 Feb 20;385(6618):733-6
9034191
J Biol Chem. 2000 May 12;275(19):14608-14
10799547
Expert Opin Investig Drugs. 2002 Jul;11(7):1003-6
12084010
J Immunol. 2005 Aug 1;175(3):1930-6
16034137
Diabetes. 2007 Nov;56(11):2790-6
17686944
Curr Opin Allergy Clin Immunol. 2007 Feb;7(1):57-62
17218812
Diabetes. 2000 Nov;49(11):1939-45
11078463
Circulation. 2004 Apr 13;109(14):1729-34
15037525
Diabetes. 1999 Apr;48(4):855-64
10102704
FASEB J. 2003 Mar;17(3):417-25
12631581
Clin Physiol. 1986 Aug;6(4):311-7
3527530
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):11059-63
1438315
J Biol Chem. 2001 Oct 12;276(41):37993-8001
11495925
J Clin Invest. 2005 Dec;115(12):3494-505
16294222
J Clin Invest. 2003 Oct;112(7):986-8
14523035
Angiology. 2005 Mar-Apr;56(2):173-89
15793607
Diabetes Care. 2005 Nov;28(11):2686-90
16249540
Arterioscler Thromb Vasc Biol. 2006 May;26(5):1086-93
16514084
Anal Biochem. 2002 Mar 15;302(2):269-75
11878807
Diabetes. 2006 Apr;55(4):901-10
16567509
Diabetes. 2005 Mar;54(3):818-29
15734861
Nature. 1994 Aug 18;370(6490):555-7
8052310
J Cereb Blood Flow Metab. 1990 Sep;10(5):631-7
2384536
Endocrinology. 2007 Sep;148(9):4371-84
17584970
Ophthalmology. 2006 Dec;113(12):2221-30
16989901
Diabetes. 2003 Aug;52(8):2102-9
12882929
Circulation. 2005 Mar 22;111(11):1398-406
15781751
Science. 1998 Nov 13;282(5392):1281-4
9812885
Circulation. 2003 Oct 21;108(16):1994-9
14517165
Circulation. 1995 Feb 15;91(4):979-89
7850985
Circulation. 2003 Jul 29;108(4):472-8
12860917
J Clin Invest. 2006 Jul;116(7):1793-801
16823477
J Am Coll Cardiol. 2003 Apr 2;41(7):1071-7
12679203
FEBS Lett. 1997 Jan 6;400(3):333-5
9009225
Br Med J (Clin Res Ed). 1986 Oct 11;293(6552):917-22
3094714
Lancet. 2002 Jun 22;359(9324):2140-4
12090978
J Biol Chem. 2003 Oct 31;278(44):42829-39
12941954
Br J Pharmacol. 2005 Jun;145(4):415-23
15806111
Clin Chim Acta. 2006 Apr;366(1-2):74-80
16343470
J Biol Chem. 1999 Jan 29;274(5):2810-5
9915814
J Clin Invest. 2005 May;115(5):1111-9
15864338
Diabetes. 2003 Jul;52(7):1799-805
12829649
Am J Physiol Cell Physiol. 2003 Feb;284(2):C263-72
12388107
Metabolism. 1979 Apr;28(4 Suppl 1):431-7
122296
EMBO J. 1998 Dec 15;17(24):7260-72
9857183
Biochem J. 1998 Jun 1;332 ( Pt 2):281-92
9601053
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4854-8
8197147
Diabetes. 2004 Jul;53(7):1773-81
15220201
Biochim Biophys Acta. 2008 May;1782(5):295-302
18325349
J Biol Chem. 1997 Jul 4;272(27):17160-5
9202036
Diabetes. 2003 Feb;52(2):442-7
12540619
Science. 1992 Oct 23;258(5082):607-14
1411571
Diabetes. 2006 Mar;55(3):774-9
16505242
Diabetes. 2003 Feb;52(2):463-9
12540622
Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R673-80
18094066
Cell. 1988 Apr 8;53(1):45-53
3349526
J Biol Chem. 1997 Sep 26;272(39):24588-93
9305925